Novartis arthritis drug fails to prove it is significantly better than rival Reuters Nov 1, 2019 Novartis said Cosentyx, when used to treat active psoriatic arthritis, "narrowly missed statistical significance for superiority"…
AbbVie looks beyond Humira with $63 billion deal for Botox-maker Allergan EP News Bureau Jun 27, 2019 AbbVie has long been under pressure to diversify its portfolio and its shares have lost more than a third of their value since…
